GlassScriptPhysician profile
Robert Dunne
NPI 1518908672
$2,206.47
in general payments reported to CMS, 2019-2025
30 companies · $170 in 2025
The $170 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $615 · 2020: $61.33 · 2021: $183 · 2022: $242 · 2023: $375 · 2024: $560 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,105.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $476.51 | 2022-2025 | Nuzyra |
| Organogenesis INC. | $187.75 | 2019-2025 | Puraply Wound Matrix |
| Wright Medical Technology, INC. | $179.92 | 2019 | |
| Horizon Therapeutics Plc | $153.12 | 2021-2022 | |
| Linvatec Corporation | $134.23 | 2023 | Quantum, Colink 2, In2bones USA |
| Cardiovascular Systems INC. | $113.88 | 2019 | |
| Arthrex, INC. | $108.66 | 2025 | |
| Stability Biologics, LLC | $105.29 | 2021 | |
| Amgen INC. | $98.85 | 2024 | Krystexxa |
| Next Science LLC | $95.39 | 2022-2023 | Xperience, Blastx, Surgx |
| Kerecis Limited | $58.55 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Sandoz INC. | $55.13 | 2019 | |
| Intuitive Surgical, INC. | $52.26 | 2020 | |
| Aroa Biosurgery Incorporated | $43.87 | 2022 | |
| Medtronic, INC. | $38.28 | 2024-2025 | Intellis Adaptivestim |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $36.97 | 2021-2023 | Exogen Ultrasound Bone Healing System |
| Convatec INC. | $35.26 | 2023-2024 | |
| Ermi LLC | $25.76 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $25.68 | 2019 | |
| Ibsa Pharma INC. | $20.85 | 2024 | Tirosint, Licart |
| Hikma Pharmaceuticals USA | $19.86 | 2019 | |
| Smith+Nephew, INC. | $19.12 | 2024 | Grafix |
| Zimvie INC. | $17.97 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $17.11 | 2023 | Seglentis |
| Musculoskeletal Transplant Foundation INC. | $16.73 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $15.01 | 2019 | |
| Mimedx Group, INC. | $14.79 | 2024 | |
| Nevro Corp. | $13.96 | 2024 | Senza |
| Reel Surgical, INC. | $13.68 | 2024 | |
| Lilly USA, LLC | $12.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dunne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.